pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
Conditions: Castration-resistant Prostate Cancer; Metastatic Cancer; Prostate Cancer Interventions: Biological: pTVG-HP; Biological: pTVG-AR; Drug: Pembrolizumab; Drug: rhGM-CSF Sponsors: University of Wisconsin, Madison; Merck Sharp & Dohme Corp.; Madison Vaccines, Inc; Prostate Cancer Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials